<p>Cytokine storm syndrome (CSS) is associated with severe damage and high mortality in acute diseases. Over-activation of M1 macrophages, accompanied with excessive pro-inflammatory cytokine secretion, drives cytokine storms, while promoting M2 macrophage polarization is a potential CSS treatment. The liver, an immune-responsive organ, secretes hepatokines such as fibroblast growth factor-21 (FGF-21) to regulate macrophage activation, but knowledge of their role in CSS-related inflammation is elusive, fueling the search for new hepatokines that can effectively fine-tune the pro-inflammatory activation of macrophages during CSS. In this study, lipopolysaccharide (LPS)-induced CSS signals increase hepatic Angiopoietin-like protein 8 (Angptl8) expression. Angptl8 knockout (Angptl8<sup>−/−</sup>) reduces mortality in high-dose LPS-treated mice. This is due to inhibited M1 and enhanced M2 macrophage polarization, decreased pro-inflammatory cytokines, and alleviated CSS symptoms. Angptl8 promotes M1 polarization by activating glycogen metabolism via c-Jun N-terminal kinase (JNK) phosphorylation. Mice treated with an Angptl8-neutralizing antibody have improved CSS symptoms, and the antibody is non-toxic in vivo. Hence, Angptl8 is a promising CSS therapeutic target. Given cytokine storms’ role in viral infections and immune therapy-related adverse reactions, targeting Angptl8 may provide new treatments, potentially improving patient outcomes and reducing morbidity and mortality.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Angiopoietin-like protein 8 orchestrates macrophage glycogen metabolism and polarization via the JNK signaling pathway in cytokine storm syndrome

  • Yang Su,
  • Rongtian Zhang,
  • Kongdong Li,
  • Hong Shen,
  • Mengjiao Nan,
  • Chang Liu,
  • Wenxiang Zhang,
  • Siyu Chen

摘要

Cytokine storm syndrome (CSS) is associated with severe damage and high mortality in acute diseases. Over-activation of M1 macrophages, accompanied with excessive pro-inflammatory cytokine secretion, drives cytokine storms, while promoting M2 macrophage polarization is a potential CSS treatment. The liver, an immune-responsive organ, secretes hepatokines such as fibroblast growth factor-21 (FGF-21) to regulate macrophage activation, but knowledge of their role in CSS-related inflammation is elusive, fueling the search for new hepatokines that can effectively fine-tune the pro-inflammatory activation of macrophages during CSS. In this study, lipopolysaccharide (LPS)-induced CSS signals increase hepatic Angiopoietin-like protein 8 (Angptl8) expression. Angptl8 knockout (Angptl8−/−) reduces mortality in high-dose LPS-treated mice. This is due to inhibited M1 and enhanced M2 macrophage polarization, decreased pro-inflammatory cytokines, and alleviated CSS symptoms. Angptl8 promotes M1 polarization by activating glycogen metabolism via c-Jun N-terminal kinase (JNK) phosphorylation. Mice treated with an Angptl8-neutralizing antibody have improved CSS symptoms, and the antibody is non-toxic in vivo. Hence, Angptl8 is a promising CSS therapeutic target. Given cytokine storms’ role in viral infections and immune therapy-related adverse reactions, targeting Angptl8 may provide new treatments, potentially improving patient outcomes and reducing morbidity and mortality.